Sienna Biopharmaceuticals Inc (SNNAQ)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE, CA 91362

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company develops, discovers, and commercializes aesthetics and dermatology based products for inflammatory skin diseases, tissue injury, and unwanted light-pigmented hair reduction. Sienna Biopharmaceuticals serves patients in the United States and Italy.

Data as of 2021-07-19 09:41:59 -0400
Market Cap370.888 Thousand Shares Outstanding22.894 Million Avg 30-day Volume55.248 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.07 / 0.002 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SNNAQ instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SNNAQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SNNAQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

AZOY ALEXANDER CHIEF FINANCIAL OFFICER

103,552 2019-10-02 0

BEDDINGFIELD III FREDERICK PRESIDENT & CEO

1,080,213 2019-08-06 0

ANDREWS TIMOTHY K. GENERAL COUNSEL & SECRETARY

170,558 2019-08-06 0

LIZZUL PAUL F. CHIEF MEDICAL OFFICER

207,045 2019-08-06 0

STROEHMANN DIANE SEE REMARKS

168,545 2019-07-02 0

FENTON DENNIS M

0 2019-05-30 0

BUROW KRISTINA

0 2019-05-30 0

LEONARD KEITH R

0 2019-05-30 0

HARRIS TODD

0 2019-05-30 0

MORE ROBERT J

0 2019-05-30 0

HINDMAN JAMES M.

0 2019-05-30 0

ARCH VENTURE PARTNERS X, LLC

ARCH VENTURE FUND X OVERAGE, L.P.

ARCH VENTURE PARTNERS X OVERAGE, L.P.

CRANDELL KEITH

NELSEN ROBERT

GILLIS STEVEN

  • 10% Owner
5,798,868 2019-02-22 0

ARCH VENTURE PARTNERS VIII, LLC

ARCH VENTURE FUND VIII, L.P.

ARCH VENTURE FUND VIII OVERAGE, L.P.

ARCH VENTURE PARTNERS VIII, L.P.

BYBEE CLINTON

CRANDELL KEITH

NELSEN ROBERT

  • 10% Owner
5,798,868 2019-02-22 0

SMITHER JOHN W CHIEF FINANCIAL OFFICER

81,618 2019-01-01 0

MAST ERLE T

0 2018-06-01 0

NELSEN ROBERT

0 2018-06-01 0

PETERSON RICHARD D CHIEF FINANCIAL OFFICER

  • Officer
7,000 2017-08-01 0

ARCH VENTURE PARTNERS VIII, LLC

ARCH VENTURE PARTNERS VIII, L.P.

ARCH VENTURE FUND VIII, L.P.

ARCH VENTURE FUND VIII OVERAGE, L.P.

BYBEE CLINTON

CRANDELL KEITH

  • 10% Owner
3,633,068 2017-08-01 0

ARCH VENTURE PARTNERS VIII, LLC

  • 10% Owner
0 2017-07-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 22:15:03 UTC -1.1632 1.2432 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 21:45:03 UTC -1.1632 1.2432 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 21:15:03 UTC -1.1632 1.2432 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 20:45:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 20:15:05 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 19:45:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 19:15:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 18:45:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 18:15:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 17:45:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 17:15:02 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 16:45:02 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 16:15:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 15:45:02 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 15:15:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 14:45:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 14:15:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 13:45:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 13:15:03 UTC -1.003 1.083 300000
SIENNA BIOPHARMACEUTICALS IN SNNAQ 2021-07-23 12:45:03 UTC -1.003 1.083 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments